Zenith TX2 Pro-Form G53424Recalls & reported problems
William Cook Europe ApS · Zenith TX2, TAA Endovascular Graft with Pro-Form, Proximal Component · Class 3 · Implant
All models of Zenith TX2 Pro-Form (15)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10827002534244), received between Feb 2, 2017 and Feb 2, 2017 — classified as 1 injury.
The most frequently reported specific device problem is “Leak/Splash” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Appropriate Device Problem Term/Code Not Available1
- Leak/Splash1
Patient problems
- Aneurysm1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryFeb 2, 2017Leak/Splash; Appropriate Device Problem Term/Code Not Available; Leak/Splash; Appropriate Device Problem Term/Code Not Available
DESCRIPTION OF EVENT ACCORDING TO STUDY: ON (B)(6) 2013: THE PATIENT RECEIVED THE FOLLOWING DEVICES: ZTEG-2P-32-120-PF-US, LOT # E3017706, PLACED JUST ABOVE CELIAC ARTERY. ZTEG-2P-42-135-PF-US, LOT #E2974777, PLACED PROXIMAL TO ABOVE DEVICE. THERE WERE NO DIFFICULTIES DEPLOYING THE DEVICES. A MOLDING BALLOON WAS USED WITHOUT DIFFICULTY OR COMPLICATIONS. NO PATIENT-RELATED ADVERSE EVENTS WERE OBSERVED DURING THE PROCEDURE. PER SITE, THE DEVICE WAS PATENT WITH NO KINK OR ENDOLEAK ON THE COMPLETION ANGIOGRAM. THE ANALYSIS NOTED A PATENT GRAFT WITH NO KINK. A PROXIMAL TYPE I AND A TYPE II ENDOLEAK WERE NOTED. (PLEASE NOTE: THIS OCCURRED PRIOR TO THE MANUFACTURER¿S REQUEST FOR REPORTING THIS EVENT). ON (B)(6) 2013 (DAY OF PROCEDURE): THE PATIENT DEVELOPED A LEFT LEG THROMBOSIS AND WAS TREATED WITH A LEFT FEMORAL-ILIO THROMBECTOMY. ON (B)(6) 2013 (THREE DAYS POST-PROCEDURE): THE PATIENT WAS DISCHARGED FROM THE HOSPITAL. ON (B)(6) 2013 (53 DAYS POST-PROCEDURE): CT SCAN. ANALYSIS REVIEW: GRAFT PATENT, INTACT WITH NO KINK. A DISTAL TYPE I ENDOLEAK AND A TYPE II ENDOLEAK WERE NOTED. MAXIMUM ANEURYSM DIAMETER = 59.0 MM. ON (B)(6) 2013 (214 DAYS POST-PROCEDURE): CT SCAN. ANALYSIS REVIEW: GRAFT
Patient problems: Aneurysm
MAUDE report 6295898 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page